Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Lowers Price Target to $9.5

Benzinga Newsdesk www.benzinga.com Negative 89.3%

Neg 89.3% Neu 0% Pos 0%

Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and lowers the price target from $11 to $9.5.